title: Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1.
abstract: Certain ritonavir resistance mutations impair HIV infectivity through incomplete Gag processing by the mutant viral protease. Analysis of the mutant virus phenotype indicates that accumulation of capsid-spacer peptide 1 precursor protein in virus particles impairs HIV infectivity and that the protease mutant virus is arrested during the early postentry stage of HIV infection before proviral DNA synthesis. However, activation of the target cell can rescue this defect, implying that specific host factors expressed in activated cells can compensate for the defect in ritonavir-resistant HIV. This ability to rescue impaired HIV replication presented a unique opportunity to identify host factors involved in postentry HIV replication, and we designed a functional genetic screen so that expression of a given host factor extracted from activated T cells would lead directly to its discovery by rescuing mutant virus replication in nonactivated T cells. We identified the cellular heat shock protein 90 kDa α (cytosolic), class B member 1 (HSP90AB1) as a host factor that can rescue impaired replication of ritonavir-resistant HIV. Moreover, we show that pharmacologic inhibition of HSP90AB1 with 17-(allylamino)-17-demethoxygeldanamycin (tanespimycin) has potent in vitro anti-HIV activity and that ritonavir-resistant HIV is hypersensitive to the drug. These results suggest a possible role for HSP90AB1 in postentry HIV replication and may provide an attractive target for therapeutic intervention.
authors: Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California 94110, USA.
authors: Pheroze
authors: P
authors: Joshi
authors: Cheryl A
authors: CA
authors: Stoddart
references: Curr Top Microbiol Immunol. 1996;214:95-131
references: 8791726
references: J Biol Chem. 2010 Dec 10;285(50):39314-28
references: 20937817
references: J Biol Chem. 2009 Oct 23;284(43):29692-703
references: 19666477
references: Cell Host Microbe. 2008 Nov 13;4(5):495-504
references: 18976975
references: Nat Med. 2001 Jun;7(6):712-8
references: 11385509
references: PLoS One. 2007 Nov 28;2(11):e1251
references: 18043758
references: EMBO J. 2001 Mar 15;20(6):1300-9
references: 11250896
references: EMBO J. 2007 Apr 18;26(8):2218-26
references: 17396149
references: Cell Mol Life Sci. 2006 Aug;63(15):1706-24
references: 16715409
references: J Virol. 2002 Jun;76(11):5667-77
references: 11991995
references: FEBS Lett. 2007 Jul 31;581(19):3758-69
references: 17559840
references: EMBO J. 1998 Mar 16;17(6):1555-68
references: 9501077
references: J Virol. 1998 Sep;72(9):7632-7
references: 9696866
references: J Mol Biol. 2008 Feb 29;376(4):1168-81
references: 18206161
references: PLoS Pathog. 2009 May;5(5):e1000437
references: 19478882
references: J Virol. 2001 Jul;75(14):6537-46
references: 11413321
references: Genomics. 2005 Dec;86(6):627-37
references: 16269234
references: Nat Rev Microbiol. 2007 Apr;5(4):253-63
references: 17325726
references: Mol Cell. 2004 Dec 22;16(6):849-59
references: 15610729
references: J Virol. 2009 Oct;83(19):9835-43
references: 19625401
references: Science. 2008 Feb 15;319(5865):921-6
references: 18187620
references: Curr Protoc Hum Genet. 2007 Jul;Chapter 12:Unit 12.10
references: 18428406
references: J Virol. 2006 Jun;80(12):5716-22
references: 16731910
references: J Clin Oncol. 2005 Feb 20;23(6):1078-87
references: 15718306
references: Methods Mol Biol. 2008;433:1-16
references: 18679614
references: Curr Opin Struct Biol. 2005 Apr;15(2):227-36
references: 15837183
references: J Virol. 2000 Sep;74(18):8524-31
references: 10954553
references: J Biol Chem. 2009 Jul 17;284(29):19463-73
references: 19460752
references: PLoS Comput Biol. 2007 May;3(5):e87
references: 17500586
references: Nat Med. 2001 May;7(5):631-4
references: 11329067
references: Cell Host Microbe. 2009 Jun 18;5(6):559-70
references: 19527883
references: J Virol. 1997 Aug;71(8):5871-7
references: 9223476
references: Cell Host Microbe. 2008 Dec 11;4(6):592-9
references: 19064259
references: Genes Dev. 2007 Jan 15;21(2):195-205
references: 17234885
references: Nat Biotechnol. 2004 Dec;22(12):1567-72
references: 15558047
references: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11914-9
references: 12154227
references: Retrovirology. 2004 May 14;1:9
references: 15169567
references: Trends Mol Med. 2004 Jun;10(6):283-90
references: 15177193
references: Cell. 1993 Jun 18;73(6):1067-78
references: 8513493
references: PLoS Pathog. 2007 Oct 26;3(10):1502-10
references: 17967060
references: Nat Biotechnol. 2002 Nov;20(11):1151-4
references: 12355096
references: Cell. 2008 Oct 3;135(1):49-60
references: 18854154
references: J Biol Chem. 2005 Dec 23;280(51):42149-55
references: 16251182
references: CSH Protoc. 2008 Apr 01;2008:pdb.prot4882
references: 21356804
references: Handb Exp Pharmacol. 2009;(189):85-110
references: 19048198
references: J Gene Med. 2001 Nov-Dec;3(6):517-28
references: 11778899
references: Biochemistry. 2008 Mar 4;47(9):2850-7
references: 18211007